<div id="readability-page-1"><ul><li>Renaissance Hedge Fund Adds NVIDIA, Follows Buffett Into UNH</li></ul><p>UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Investment analysts at Zacks Research lifted their Q2 2027 earnings estimates for UnitedHealth Group in a report issued on Wednesday, August 20th. Zacks Research analyst Team now forecasts that the healthcare conglomerate will post earnings of $4.57 per share for the quarter, up from their previous estimate of $4.53. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><p>Several other research analysts have also commented on the stock. Wolfe Research dropped their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an &#34;outperform&#34; rating for the company in a research note on Tuesday, May 20th. Baird R W lowered shares of UnitedHealth Group from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research note on Thursday, July 31st. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday, May 14th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an &#34;overweight&#34; rating for the company in a research note on Wednesday, July 30th. Finally, Robert W. Baird  reaffirmed an &#34;underperform&#34; rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock  has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $365.38.</p><ul><li>Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH</li></ul><p><b>Read Our Latest Stock Analysis on UnitedHealth Group</b></p><h2>UnitedHealth Group Trading Up 1.2%</h2><p>Shares of UNH opened at $307.0980 on Monday. The company's fifty day moving average is $288.39 and its 200 day moving average is $387.54. UnitedHealth Group has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a market capitalization of $278.13 billion, a PE ratio of 13.31, a P/E/G ratio of 1.98 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. </p><ul><li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li></ul><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the firm posted $6.80 EPS. The company's revenue for the quarter was up 12.9% on a year-over-year basis.  UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS.</p><h2>UnitedHealth Group Announces Dividend</h2><p>The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group's dividend payout ratio  is 38.30%. </p><h2>Insider Buying and Selling</h2><p>In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own  0.28% of the company's stock. </p><h2>Hedge Funds Weigh In On UnitedHealth Group</h2><p>Large investors have recently added to or reduced their stakes in the company. Marshall &amp; Sterling Wealth Advisors Inc. bought a new position in  UnitedHealth Group in the fourth quarter worth about $26,000.  Bayforest Capital Ltd increased its holdings in shares of  UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter.  Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of  UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares in the last quarter.  IAG Wealth Partners LLC acquired a new position in shares of  UnitedHealth Group during the first quarter valued at about $42,000.  Finally, LFA Lugano Financial Advisors SA acquired a new position in shares of  UnitedHealth Group during the second quarter valued at about $25,000. 87.86% of the stock is currently owned by institutional investors. </p><h2>About UnitedHealth Group</h2> (Get Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Compound Interest and Why It Matters When Investing</li><li>Costco and Ross: 2 Ways to Play the Consumer Divide</li><li>Natural Gas Prices Continue To Rally, These Stocks Should Benefit</li><li>Is Paramount Skydance a Buy Post-Merger, Short Squeeze?</li><li>Stock Market Sectors: What Are They and How Many Are There? </li><li>V2X Stock: Defense Underdog Riding a $4.3B Air Force Contract</li></ul> <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Zacks Research has raised its Q2 2027 earnings estimate for UnitedHealth Group (NYSE: UNH) from $4.53 to $4.57 per share. The consensus estimate for the full year is $29.54 per share. Despite mixed ratings from various analysts, the stock has an average rating of "Moderate Buy" with a price target of $365.38. UnitedHealth's recent quarterly earnings missed expectations, reporting $4.08 EPS against a $4.45 estimate. The company also announced a quarterly dividend of $2.21, payable on September 23rd.</p>

Zacks Research Issues Optimistic Outlook for UNH Earnings